Location
Parker-Reed, SSWAC
Start Date
1-5-2014 10:00 AM
End Date
1-5-2014 11:00 AM
Project Type
Poster
Description
Viral pathogens present researchers, physicians, and public health workers with the challenges of developing new treatments in an every-changing landscape of antiviral drug resistance. This paper outlines the basis of current knowledge in virology, how that knowledge is applied when developing treatments such as integrase and protease inhibitors, neuraminidase inhibitors, nucleotide analogs, and others, and considers the rates of resistance of the target viruses to those treatments. There is also some consideration of immunomodulatory treatments and the potential of viral vectors as a means of understanding different immune responses to viruses and the direct effects that viruses can have on the immune systems. The combined information in this paper supports combined immunomodulatory and direct treatment methods for viral infections as a means of limiting the development of resistance while still providing adequate patient care.
Sponsoring Department
Colby College. Biology Dept.
CLAS Field of Study
Natural Sciences
Event Website
http://www.colby.edu/clas
ID
184
Included in
Analysis of Current Clinical Antiviral Treatment Approaches and Medications and Related Suggestions for Future Research
Parker-Reed, SSWAC
Viral pathogens present researchers, physicians, and public health workers with the challenges of developing new treatments in an every-changing landscape of antiviral drug resistance. This paper outlines the basis of current knowledge in virology, how that knowledge is applied when developing treatments such as integrase and protease inhibitors, neuraminidase inhibitors, nucleotide analogs, and others, and considers the rates of resistance of the target viruses to those treatments. There is also some consideration of immunomodulatory treatments and the potential of viral vectors as a means of understanding different immune responses to viruses and the direct effects that viruses can have on the immune systems. The combined information in this paper supports combined immunomodulatory and direct treatment methods for viral infections as a means of limiting the development of resistance while still providing adequate patient care.
https://digitalcommons.colby.edu/clas/2014/program/123